Impaired proteasome function in Alzheimer's disease

Journal of Neurochemistry

Volumn 75, Issue 1, 2000, Pages 436-439

  Keller, Jeffrey N ^a   Hanni, Keith B ^a   Markesbery, William R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Neurodegeneration; Oxidative stress; Proteasome; Ubiquitin

Indexed keywords

AMYLOID BETA PROTEIN; PROTEASOME; UBIQUITIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; SUBICULUM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYSTEINE ENDOPEPTIDASES; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MULTIENZYME COMPLEXES; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; TEMPORAL LOBE;

EID: 0034131044     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750436.x     Document Type: Article

References (28)

1. Benzi G. and Moretti A. (1995) Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic. Biol. Med. 19, 77-101.
2. Boutillier A. L., Kienlen-Campard P., and Loeffler J. P. (1999) Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway. Eur. J. Neurosci. 11, 441-448.
3. Braak H. and Braak E. (1994) Pathology of Alzheimer's disease, in Neurodegenerative Diseases (Calne D. B., ed), pp. 585-614. W. B. Saunders, Philadelphia.
4. Butterfield D. A., Howard B., Yatin S., Koppal T., Drake J., Hensley K., Aksenov M., Aksenova M., Subramaniam R., Varadarajan S., Harris-White M. E., Pedigo N. W., and Carney J. M. (1999) Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci. 65, 1883-1892.
5. Coux O., Tanaka K., and Goldberg A. L. (1996) Structure and function of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847.
6. Friguet B. and Szweda L. I. (1997) Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal crosslinked protein. FEBS Lett. 405, 21-25.
7. Gregori L., Fuchs C., Figueiredo-Pereira M. E., Van Nostrand W. E., and Goldgaber D. (1995) Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270, 19702-19708.
8. Grune T., Reinheckel T., Joshi M., and Davies K. J. A. (1995) Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270, 2344-2351.
9. Grune T., Reinheckel T., and Davies K. J. A. (1997) Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526-534.
10. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
11. Hershko A. and Ciechanover A. (1992) The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61, 761-807.
12. Keller J. N., Kindy M. S., Holtsberg F. W., St. Clair D. K., Yen H. C., Germeyer A., Steiner S. M., Bruce-Keller A. J., Hutchins J. B., and Mattson M. P. (1998) Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci. 18, 687-697.
13. Keller J. N., Hanni K. B., and Markesbery W. R. (2000) Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 113, 61-70.
14. Lopes U. G., Erhardt P., Yao R., and Cooper G. M. (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272, 12893-12896.
15. Lovell M. A., Ehmann W. D., Mattson M. P., and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
16. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
17. Markesbery W. R. and Carney J. M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9, 133-146.
18. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
19. Mattson M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
21. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., and Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
22. National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18 (Suppl. 4), S1-S2.
23. Qiu J. H., Asai A., Chi S., Saito N., Hamada H., and Kirino T. (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20, 259-265.
24. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K. J., and Grune T. (1998) Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J. 335, 637-642.
25. Rock K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A. L. (1994) Inhibitors of the proteosome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell 78, 761-771.
26. Sadoul R., Fernandez P. A., Quiquerez A. L., Martinou I., Maki M., Schroter M., Becherer J. D., Irmler M., Tschopp J., and Martinou J. C. (1996) Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15, 3845-3852.
27. Tanaka K. (1998) Proteasomes: structure and biology. J. Biochem. (Tokyo) 123, 195-204.
28. Tanaka K. and Chiba T. (1998) The proteosome: a protein-destroying machine. Genes Cells 3, 499-510.